Trademark search for:

ACLAZPRE

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results

Also check across:

USPTO Filing History

Key events recorded for this trademark application

2004-08-12 — Application filed
2004-08-20 — Application filed
2004-12-06 — Paper received
2004-12-06 — Correspondence received in law office
2004-12-19 — Teas change of correspondence received
2004-12-21 — Amendment from applicant entered
2005-02-25 — Assigned to examiner
2005-02-26 — Priority action written
2005-02-26 — Priority action e-mailed
2005-03-01 — Examiners amendment -written
2005-03-01 — Priority action written
2005-03-01 — Priority action e-mailed
2005-03-01 — Examiners amendment e-mailed
2005-03-04 — Office action issued
2005-03-04 — Correspondence received in law office
2005-03-11 — Teas/email correspondence entered
2005-03-12 — Approved for pub - principal register
2005-03-18 — Assigned to lie
2005-03-24 — Law office publication review completed
2005-06-08 — Notice of publication
2005-06-28 — Published for opposition
2005-09-20 — Registered-principal register
2009-06-20 — Teas change of correspondence received
2012-10-12 — Cancelled sec. 8 (6-yr)
2012-10-12 — Final status recorded

Owner Information

Novartis AG
Basel CH

Correspondent

MAURY M. TEPPER, III Tepper & Eyster, PLLC
3724 Benson Drive
Raleigh, NC 27609
UNITED STATES

Filing Details

Filing Date:
2004-08-12

Status Date:
2012-10-12

Category:
Pharmaceuticals

Filing Year:
2004

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.